⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28019872 | 0.83 | — | — | |
| SCHEMBL27726692 | 0.69 | — | — | |
| SCHEMBL23829672 | 0.64 | — | — | |
| Acetamide SCHEMBL20411649 | 0.59 | — | — | |
| Acetamide SCHEMBL4953249 | 0.59 | LMNA (1.00) | — | |
| Acetamide SCHEMBL3337894 | 0.59 | LMNA (1.00) | — | |
| Acetamide SCHEMBL2232674 | 0.59 | — | — | |
| Urea SCHEMBL1705605 | 0.59 | — | — | |
| Urea SCHEMBL9555545 | 0.59 | — | — | |
| Acetamide SCHEMBL20411647 | 0.59 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9580397-B2 | Process and apparatus for producing divinylarene dioxide | BLUE CUBE IP LLC (US) | 2017-02-28 | — | — | US | claimed |
| EP-3500549-B1 | NEW PROCESSES AND INTERMEDIATES FOR NEP INHIBITOR SYNTHESIS | NOVARTIS AG (CH) | 2020-12-16 | — | — | EP | disclosed |
| US-10851059-B2 | Processes and intermediates for NEP inhibitor synthesis | NOVARTIS AG (CH) | 2020-12-01 | — | — | US | disclosed |
| US-20190202785-A1 | NEW PROCESSES AND INTERMEDIATES FOR NEP INHIBITOR SYNTHESIS | NOVARTIS PHARMA AG (CH) | 2019-07-04 | — | — | US | disclosed |
| EP-3500549-A1 | NEW PROCESSES AND INTERMEDIATES FOR NEP INHIBITOR SYNTHESIS | Novartis AG (CH) | 2019-06-26 | — | — | EP | disclosed |
| EP-3010897-B1 | PROCESS AND APPARATUS FOR PRODUCING DIVINYLARENE DIOXIDE | BLUE CUBE IP LLC (US) | 2018-08-22 | — | — | EP | disclosed |
| WO-2018033866-A1 | NEW PROCESSES AND INTERMEDIATES FOR NEP INHIBITOR SYNTHESIS | NOVARTIS AG (CH) | 2018-02-22 | — | — | WO | disclosed |
| US-9580397-B2 | Process and apparatus for producing divinylarene dioxide | BLUE CUBE IP LLC (US) | 2017-02-28 | — | — | US | disclosed |
| EP-2516409-B1 | PROCESS FOR PREPARING DIVINYLARENE DIOXIDES | BLUE CUBE IP LLC (US) | 2017-01-25 | — | — | EP | disclosed |
| US-20160130242-A1 | PROCESS AND APPARATUS FOR PRODUCING DIVINYLARENE DIOXIDE | DOW GLOBAL TECHNOLOGIES LLC | 2016-05-12 | — | — | US | disclosed |
| US-20130267720-A1 | PROCESS FOR PREPARING DINVINYLARENE OXIDES | DOW GLOBAL TECHNOLOGIES LLC (US) | 2013-10-10 | — | — | US | disclosed |
| EP-2516409-A1 | PROCESS FOR PREPARING DIVINYLARENE DIOXIDES | Dow Global Technologies LLC (US) | 2012-10-31 | — | — | EP | disclosed |
| US-20120253055-A1 | PROCESS FOR PREPARING DIVINYLARENE DIOXIDES | DOW GLOBAL TECHNOLOGIES LLC | 2012-10-04 | — | — | US | disclosed |
| WO-2012082482-A1 | PROCESS FOR PREPARING DIVINYLARENE OXIDES | DOW GLOBAL TECHNOLOGIES LLC (US) | 2012-06-21 | — | — | WO | disclosed |
| WO-2011084687-A1 | PROCESS FOR PREPARING DIVINYLARENE DIOXIDES | DOW GLOBAL TECHNOLOGIES INC. (US) | 2011-07-14 | — | — | WO | disclosed |
| US-20110009615-A1 | METHOD FOR PRODUCING A STEROID COMPOUND | MITSUBISHI CHEMICAL GROUP SCIENCE AND TECHNOLOGY RESEARCH CENTER, INC. (JP) | 2011-01-13 | — | — | US | disclosed |
| US-20100063272-A1 | METHOD FOR PRODUCING STEROID COMPOUND | MITSUBISHI CHEMICAL CORPORATION (JP) | 2010-03-11 | — | — | US | disclosed |
| EP-1985621-A1 | PROCESS FOR PRODUCTION OF STEROIDS | Mitsubishi Chemical Corporation (JP) | 2008-10-29 | — | — | EP | disclosed |
| EP-1775304-A1 | PROCESS FOR PRODUCTION OF STEROIDS | Mitsubishi Chemical Corporation (JP) | 2007-04-18 | — | — | EP | disclosed |
| US-20060252948-A1 | Production method of steroid compound | MITSUBISHI CHEMICAL CORPORATION (JP) | 2006-11-09 | — | — | US | disclosed |